Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep-Oct;39(5):1406-1410.
doi: 10.12669/pjms.39.5.7138.

A comparative study between Dydrogesterone alone and combined with Non-Steroidal Anti-Inflammatory Drugs in the treatment of Mild Endometriosis

Hui-Ling Xue  1 , Wan-Jiao Hao  2 , Bing Wang  3
Affiliations

A comparative study between Dydrogesterone alone and combined with Non-Steroidal Anti-Inflammatory Drugs in the treatment of Mild Endometriosis

Hui-Ling Xue et al. Pak J Med Sci. 2023 Sep-Oct.

Abstract

Objective: To evaluate the clinical efficacy of dydrogesterone combined with non-steroidal anti-inflammatory drugs(NSAIDs) in the treatment of patients with mild endometriosis.

Methods: This was a clinical comparative study. Eighty patients with mild endometriosis were recruited at Affiliated Hospital of Hebei University, randomly divided experimental group (n=40) and control group (n=40) from March 2022 to March 2023. Both groups started treatment with dydrogesterone on the 5th day of menstruation. Patients in the control group were treated with dydrogesterone monotherapy, while those in the experimental group were treated with mefenamic acid the basis of the therapy of the control group. The clinical efficacy, differences in the levels of humoral immune indexes, the levels of inflammatory factor and the incidence of adverse drug reactions of the two groups was compared and analyzed.

Results: The efficacy of the experimental group was significantly higher than the control group, with a statistically significant difference(P=0.02). The levels of C3 and C4 in the experimental group after treatment were significantly lower than those in the control group, with a statistically significant difference(P=0.00). After treatment, TNF-a, CRP, IL-6 and other indexes in the experimental group were significantly lower than those in the control group, with statistically significant differences(P=0.00). The incidence of adverse reactions after treatment had no statistically significant difference(P=0.45).

Conclusion: Dydrogesterone combined with non-steroidal anti-inflammatory drugs is a safe and effective treatment for patients with endometriosis. It can improve various obvious curative effects, such as marked relief of pain symptoms, reduction of complement and inflammatory factor levels without a significant increase in adverse reactions.

Keywords: Dydrogesterone; Endometriosis; Non-steroidal anti-inflammatory; Treatment.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None.

Similar articles

See all similar articles

Cited by

References

    1. Falcone T, Flyckt R. Clinical Management of Endometriosis. Obstet Gynecol. 2018;131(3):557–571. doi: 10.1097/AOG.0000000000002469. - PubMed
    1. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease:clinical challenges and novel innovations. Lancet. 2021;397(10276):839–852. doi: 10.1016/S0140-6736(21)00389-5. - PubMed
    1. Rolla E. Endometriosis:advances and controversies in classification, pathogenesis, diagnosis, and treatment. F1000Res. 2019;8 F1000 Faculty Rev-529. doi: 10.12688/f1000research.14817.1. - PMC - PubMed
    1. Guimarães I, Póvoa AM. Primary Dysmenorrhea:Assessment and Treatment. Dismenorreia primária:Avaliação e tratamento. Rev Bras Ginecol Obstet. 2020;42(8):501–507. doi: 10.1055/s-0040-1712131. - PMC - PubMed
    1. Yang Y, Zhu W, Chen S, Zhang G, Chen M, Zhuang Y. Laparoscopic Surgery Combined with GnRH Agonist in Endometriosis. J Coll Physicians Surg Pak. 2019;29(4):313–316. doi: 10.29271/jcpsp.2019.04.313. - PubMed

LinkOut - more resources